The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Jarrett Jennifer since 2021.
This trader's CIK number is 1671311.
At the time of last reporting, Jarrett Jennifer was the Chief Operating Officer of Arcus Biosciences, Inc.. (stock ticker symbol RCUS).
Also see all insider trading activities at Arcus Biosciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | RCUS | 0 | $0 | 83,625 | $1,625,860 | 0 | $0 |
| 2023 | RCUS | 0 | $0 | 121,619 | $2,348,251 | 0 | $0 |
| 2022 | RCUS | 0 | $0 | 34,989 | $908,746 | 0 | $0 |
| 2021 | RCUS | 0 | $0 | 112,492 | $4,159,581 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-03-27 | RCUS | Sale | 11,551 | 17.55 | 202,720 |
| 2024-03-18 | RCUS | Sale | 13,449 | 18.23 | 245,175 |
| 2024-02-26 | RCUS | Sale | 24,555 | 20.07 | 492,818 |
| 2024-02-27 | RCUS | Sale | 34,070 | 20.11 | 685,147 |
| 2023-12-22 | RCUS | Sale | 21,521 | 17.76 | 382,212 |
| 2023-09-22 | RCUS | Sale | 21,369 | 19.99 | 427,166 |
| 2023-07-28 | RCUS | Sale | 45,000 | 20.25 | 911,250 |
| 2023-06-22 | RCUS | Sale | 12,437 | 19.12 | 237,795 |
| 2023-06-16 | RCUS | Sale | 12,563 | 19.35 | 243,094 |
| 2023-03-16 | RCUS | Sale | 8,729 | 16.81 | 146,734 |
| 2022-09-16 | RCUS | Sale | 12,677 | 26.28 | 333,151 |
| 2022-06-16 | RCUS | Sale | 6,081 | 20.72 | 125,998 |
| 2022-06-17 | RCUS | Sale | 6,614 | 22.00 | 145,508 |
| 2022-03-16 | RCUS | Sale | 9,617 | 31.62 | 304,089 |
| 2021-12-20 | RCUS | Sale | 34,822 | 41.60 | 1,448,595 |
| 2021-12-17 | RCUS | Sale | 7,118 | 40.11 | 285,531 |
| 2021-12-16 | RCUS | Sale | 5,560 | 40.02 | 222,533 |
| 2021-09-20 | RCUS | Sale | 30,634 | 35.40 | 1,084,566 |
| 2021-09-21 | RCUS | Sale | 16,866 | 35.74 | 602,790 |
| 2021-06-16 | RCUS | Sale | 3,968 | 24.45 | 97,017 |
| 2021-06-17 | RCUS | Sale | 4,863 | 23.68 | 115,155 |
| 2021-03-16 | RCUS | Sale | 8,661 | 35.03 | 303,394 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Jarrett Jennifer (Chief Operating Officer of Arcus Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.